Creating Hope Reauthorization Act

Summary

Creating Hope Reauthorization Act This bill permanently reauthorizes a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

10 official files

• Received in Senate (text)

  Received in Senate · EN · 30 September 2020

  ViewDownloadOpen at official source

• Received in Senate (PDF)

  Received in Senate · EN · 30 September 2020

  ViewDownloadOpen at official source

• Engrossed in House (text)

  Engrossed in House · EN · 29 September 2020

  ViewDownloadOpen at official source

• Engrossed in House (PDF)

  Engrossed in House · EN · 29 September 2020

  ViewDownloadOpen at official source

• Reported in House (text)

  Reported in House · EN · 29 September 2020

  ViewDownloadOpen at official source

• Reported in House (PDF)

  Reported in House · EN · 29 September 2020

  ViewDownloadOpen at official source

• Passed House

  summary · EN · 29 September 2020

  Open at official source

• Introduced in House (text)

  Introduced in House · EN · 20 September 2019

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 20 September 2019

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 20 September 2019

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.